104 related articles for article (PubMed ID: 11206636)
1. Late esophageal toxicity using a combination of external beam radiation, intraluminal brachytherapy and 5-fluorouracil infusion in carcinoma of the esophagus.
Sharma V; Agarwal J; Dinshaw K; Nehru RM; Mohandas M; Deshpande R; Rayabhattnavar S
Dis Esophagus; 2000; 13(3):219-25. PubMed ID: 11206636
[TBL] [Abstract][Full Text] [Related]
2. A phase I/II study of external beam radiation, brachytherapy and concurrent chemotherapy in localized cancer of the esophagus (RTOG 92-07): preliminary toxicity report.
Gaspar LE; Qian C; Kocha WI; Coia LR; Herskovic A; Graham M
Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):593-9. PubMed ID: 9112458
[TBL] [Abstract][Full Text] [Related]
3. A phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus (Radiation Therapy Oncology Group Study 9207): final report.
Gaspar LE; Winter K; Kocha WI; Coia LR; Herskovic A; Graham M
Cancer; 2000 Mar; 88(5):988-95. PubMed ID: 10699886
[TBL] [Abstract][Full Text] [Related]
4. High-dose-rate brachytherapy boost following concurrent chemoradiotherapy for esophageal carcinoma.
Yorozu A; Dokiya T; Oki Y
Int J Radiat Oncol Biol Phys; 1999 Sep; 45(2):271-5. PubMed ID: 10487545
[TBL] [Abstract][Full Text] [Related]
5. Radical radiotherapy incorporating a brachytherapy boost for the treatment of carcinoma of the thoracic oesophagus: results from a cohort of patients and review of the literature.
Churn M; Jones B; Myint AS
Clin Oncol (R Coll Radiol); 2002 Apr; 14(2):117-22. PubMed ID: 12069118
[TBL] [Abstract][Full Text] [Related]
6. Esophageal cancer. A prospective phase II study of concomitant-boost external-beam chemoradiation with a top-up endoluminal boost.
Brunner TB; Rupp A; Melzner W; Grabenbauer GG; Sauer R
Strahlenther Onkol; 2008 Jan; 184(1):15-22. PubMed ID: 18188518
[TBL] [Abstract][Full Text] [Related]
7. Results of external irradiation and low-dose-rate intraluminal brachytherapy for esophageal cancer.
Someya M; Sakata K; Saito A; Nagakura H; Oouchi A; Hareyama M
Acta Oncol; 2002; 41(1):63-8. PubMed ID: 11990521
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of chemoradiotherapy with low-dose cisplatin and continuous infusion of 5-fluorouracil for unresectable squamous cell carcinoma of the esophagus.
Takagawa R; Kunisaki C; Makino H; Kosaka T; Ono HA; Akiyama H; Shimada H
Dis Esophagus; 2009; 22(6):482-9. PubMed ID: 19191850
[TBL] [Abstract][Full Text] [Related]
9. A retrospective study of external beam radiation, neutron brachytherapy, and concurrent chemotherapy for patients with localized advanced carcinoma of the esophagus.
Ma K; Wang Q; Li T; Liu H; Liu B; Jia X; Li S; Lang J; Zhang M
Radiat Oncol; 2014 Dec; 9():294. PubMed ID: 25515326
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of radical treatment of carcinoma esophagus using a combination of external beam and intracavitary irradiation.
Sur RK; Kochhar R; Singh DP; Sharma SC; Goenka MK; Negi PS; Gupta BD; Mehta SK
Indian J Gastroenterol; 1992 Jul; 11(3):121-3. PubMed ID: 1506047
[TBL] [Abstract][Full Text] [Related]
11. Swallowing function and weight change observed in a phase I/II study of external-beam radiation, brachytherapy and concurrent chemotherapy in localized cancer of the esophagus (RTOG 9207).
Gaspar LE; Winter K; Kocha WI; Pinover WH; Herskovic ; Graham M; Gunderson L
Cancer J; 2001; 7(5):388-94. PubMed ID: 11693897
[TBL] [Abstract][Full Text] [Related]
12. Intraluminal high-dose-rate brachytherapy for palliation of dysphagia in cancer of the esophagus: initial experience at a single UK center.
Bhatt L; Tirmazy S; Sothi S
Dis Esophagus; 2013 Jan; 26(1):57-60. PubMed ID: 22404484
[TBL] [Abstract][Full Text] [Related]
13. Multi-institutional randomized trial of external radiotherapy with and without intraluminal brachytherapy for esophageal cancer in Japan. Japanese Society of Therapeutic Radiology and Oncology (JASTRO) Study Group.
Okawa T; Dokiya T; Nishio M; Hishikawa Y; Morita K
Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):623-8. PubMed ID: 10524414
[TBL] [Abstract][Full Text] [Related]
14. Concurrent radiotherapy and chemotherapy with protracted continuous infusion of 5-fluorouracil in inoperable esophageal squamous cell carcinoma.
Sakai K; Inakoshi H; Sueyama H; Oda J; Ito T; Tsuchida E; Sugita T; Matsumoto Y; Saito M; Saito A
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):921-7. PubMed ID: 7860407
[TBL] [Abstract][Full Text] [Related]
15. External beam radiotherapy and intraluminal brachytherapy in advanced inoperable esophageal cancer: JIPMER experience.
Vivekanandam S; Reddy KS; Velavan K; Balasundaram V; Ranga Rao S; Subba Rao KS; Nachiappan M
Am J Clin Oncol; 2001 Apr; 24(2):128-30. PubMed ID: 11319284
[TBL] [Abstract][Full Text] [Related]
16. Concurrent chemoradiotherapy for locally advanced esophageal cancer--a pilot study by using daily low-dose cisplatin and continuous infusion of 5-fluorouracil.
Hsu CH; Yeh KH; Lui LT; Lee YC; Bu CF; Wang HP; Lin JT; Cheng AL
Anticancer Res; 1999; 19(5C):4463-7. PubMed ID: 10650793
[TBL] [Abstract][Full Text] [Related]
17. Treatment results of chemoradiotherapy for clinical stage I (T1N0M0) esophageal carcinoma.
Yamada K; Murakami M; Okamoto Y; Okuno Y; Nakajima T; Kusumi F; Takakuwa H; Matsusue S
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1106-11. PubMed ID: 16504758
[TBL] [Abstract][Full Text] [Related]
18. External beam and intraluminal radiotherapy in the treatment of carcinoma of the esophagus.
Hyden EC; Langholz B; Tilden T; Lam K; Luxton G; Astrahan M; Jepson J; Petrovich Z
J Thorac Cardiovasc Surg; 1988 Aug; 96(2):237-41. PubMed ID: 3398546
[TBL] [Abstract][Full Text] [Related]
19. The safety and usefulness of high-dose-rate endoluminal brachytherapy as a boost in the treatment of patients with esophageal cancer with external beam radiation with or without chemotherapy.
Vuong T; Szego P; David M; Evans M; Parent J; Mayrand S; Corns R; Burtin P; Faria S; Devic S
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):758-64. PubMed ID: 16199311
[TBL] [Abstract][Full Text] [Related]
20. Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group trial (JCOG9516).
Ishida K; Ando N; Yamamoto S; Ide H; Shinoda M
Jpn J Clin Oncol; 2004 Oct; 34(10):615-9. PubMed ID: 15591460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
